Log in to search using one of your social media accounts:

 

Second U.S. jury finds AbbVie misrepresented risks of AndroGel
(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in a statement. (Source: Reuters: Health)
Source: Reuters: Health - October 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

AbbVie hit with $140 million verdict in AndroGel trial: lawyer
(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in an emailed statement. (Source: Reuters: Health)
Source: Reuters: Health - October 5, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Dose-Response Effects of T Gel in Medically Castrated Men Dose-Response Effects of T Gel in Medically Castrated Men
A new study examines the treatment effects of variable doses of transdermal testosterone gel among medically castrated men.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

U.S. Jury Finds AbbVie Liable for Misrepresentation in First AndroGel Verdict U.S. Jury Finds AbbVie Liable for Misrepresentation in First AndroGel Verdict
A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 25, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

U.S. jury finds AbbVie liable for misrepresentation in AndroGel verdict
NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. jury finds AbbVie liable for misrepresentation in first AndroGel verdict
NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. (Source: Reuters: Health)
Source: Reuters: Health - July 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Testosterone Replacement Gel Therapy for Male Hypogonadism Testosterone Replacement Gel Therapy for Male Hypogonadism
This novel testosterone gel formulation may be an effective new treatment option for hypogonadal men.Endocrine Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Axiron vs. Androgel
Title: Axiron vs. AndrogelCategory: MedicationsCreated: 4/19/2017 12:00:00 AMLast Editorial Review: 4/19/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - April 19, 2017 Category: Drugs & Pharmacology Source Type: news

Axiron vs. Androgel Testosterone Supplements
Title: Axiron vs. Androgel Testosterone SupplementsCategory: MedicationsCreated: 4/18/2017 12:00:00 AMLast Editorial Review: 4/18/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - April 18, 2017 Category: Drugs & Pharmacology Source Type: news

Morning Report: Vertigo, Insect Repellents, Testosterone Gel Morning Report: Vertigo, Insect Repellents, Testosterone Gel
Dr Arefa Cassoobhoy highlights some of this week's most important medical news.Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2017 Category: Consumer Health News Tags: Internal Medicine Commentary Source Type: news

Testosterone Therapy: Five New Reports Offer a Mixed Bag (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH New findings from the NIH-supported " Testosterone Trials " offer a mixed take on the potential role of testosterone therapy in older men. In the trials, men aged 65 and older with serum testosterone below 275 ng/dL plus sexual or physical dysfunction or reduced vitality were randomized to use testosterone gel (1%) or placebo for 1 year.Among the findings, as reported … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 21, 2017 Category: Primary Care Source Type: news

Testosterone gel study finds no memory benefit
Testosterone treatment did not improve older men's memory or mental function, according to a new study (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 21, 2017 Category: Consumer Health News Source Type: news

Fortesta (Testosterone Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2016 Category: Drugs & Pharmacology Source Type: news

Vogelxo (Testosterone Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 9, 2016 Category: Drugs & Pharmacology Source Type: news

AndroGel 1.62 (Testosterone Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 7, 2016 Category: Drugs & Pharmacology Source Type: news

AndroGel (Testosterone Gel for Topical Use) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 7, 2016 Category: Drugs & Pharmacology Source Type: news

Testim (Testosterone Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2016 Category: Drugs & Pharmacology Source Type: news

Testosterone gel boosts sexual desire and activity in older men
(Reuters Health) - Older men with low testosterone levels and scant desire for sex report more interest and more sexual activity after testosterone therapy, according to a new study. (Source: Reuters: Health)
Source: Reuters: Health - July 4, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Testosterone Therapy May Boost Older Men's Sex Lives
WEDNESDAY, June 29, 2016 -- Aging men who are losing their sexual pep can receive a love-life boost from testosterone replacement therapy, according to results from the largest "low-T" clinical trial to date. Older men treated with testosterone gel... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 29, 2016 Category: Journals (General) Source Type: news

Medical News Today: Testosterone gel boosts sexual function, mood for older men
Early results from the largest trials of testosterone therapy to date reveals that a testosterone gel improved sexual function, mood and walking ability for men aged 65 and older. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 19, 2016 Category: Consumer Health News Tags: Men's Health Source Type: news

Testosterone gel is no fountain of youth, study finds
New study shows certain benefits of the therapy, while questions about risks still remain (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 18, 2016 Category: Consumer Health News Source Type: news

Testosterone Therapy Boosts Libido In Older Men -- But Not This
  Could this be the male version of "I'm not in the mood, Honey?"  A University of Pennsylvania study published in the New England Journal of Medicine found that men 65 and older responded favorably when treated with a gel containing the male hormone testosterone inasmuch as they saw modest gains in their sex drive. But the treatments did little to improve their vitality or how far they could walk.  The gel was tested in seven different trials. The new report looked only at the trials that assessed the impact of the testosterone gel on sexual function, physical function and vitality. Data on its ...
Source: Healthy Living - The Huffington Post - February 18, 2016 Category: Consumer Health News Source Type: news

Testosterone gel has modest effect for older men
Stephen FellerPHILADELPHIA, Feb. 18 (UPI) -- A recent set of studies found testosterone replacement for men over 65 modestly improves sexual function, walking ability, and mood, researchers reported. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 18, 2016 Category: Consumer Health News Source Type: news

Testosterone gel has modest benefits for men
Research published in the New England Journal of Medicine suggest testosterone gel may provide only modest benefits and that more conservative use should be suggested. NY Times (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 18, 2016 Category: Endocrinology Source Type: news

Testosterone Treatment Shown to Benefit Men Over 65
University of Pittsburgh Graduate School of Public Health was among a dozen sites in the first clinical trial to show testosterone gel improves sexual function in men over 65.(PRWeb February 17, 2016)Read the full story at http://www.prweb.com/releases/2016/02/prweb13213974.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 18, 2016 Category: Pharmaceuticals Source Type: news

Testosterone Gel Has Modest Benefits for Men, Study Says
Using the gel seemed to improve sexual functioning, but little else, in landmark research published Wednesday in The New England Journal of Medicine. (Source: NYT Health)
Source: NYT Health - February 17, 2016 Category: Consumer Health News Authors: GINA KOLATA Tags: National Institutes of Health Drugs (Pharmaceuticals) Hormones Men Over 65 AbbVie Inc Testosterone Source Type: news

Study finds testosterone gel is no fountain of youth
CHICAGO (AP) — A landmark study suggests that testosterone treatment is no fountain of youth, finding mostly modest improvement in the sex lives, walking strength and mood of a select group of older men. (Source: U.S. News - Health)
Source: U.S. News - Health - February 17, 2016 Category: Consumer Health News Source Type: news

Testosterone Boosts Libido And Mood In Study -- But Beware Of Caveats
A key study credits AbbVie's AndroGel testosterone drug for improving the sex lives of older men and other benefits, but that doesn't mean everyone should rush out and get prescriptions for the hormone. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 17, 2016 Category: Pharmaceuticals Authors: Arlene Weintraub Source Type: news

How The 'Low T' Wars Cast A Shadow Over Repros' Testosterone Alternative
Repros is trying to win approval for a pill that it believes can raise testosterone levels without the downsides of drugs like AbbVie's AndroGel. The FDA, however, seems to have serious doubts. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 3, 2015 Category: Pharmaceuticals Authors: Arlene Weintraub Source Type: news

Testosterone Suits Soar Past 2,500 As Legal Milestone Looms for AbbVie
Sales of AbbVie's embattled testosterone drug AndroGel fell in what was otherwise a strong quarter for the company. Now AbbVie is facing the selection of the bellwether cases to be tried next year involving men who believe they were harmed by the gel. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 30, 2015 Category: Pharmaceuticals Authors: Arlene Weintraub Source Type: news

Estrogen Modulator Boosts T in Hypogonadal Men, Trial Finds (CME/CE)
(MedPage Today) -- Phase III study compared novel oral agent with testosterone gel (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 29, 2015 Category: Endocrinology Source Type: news

Restoring testosterone rather than replacing it helps safeguard a man's fertility
Restoring testosterone production in men may be as effective as replacing it, without compromising their fertility. Two phase III clinical trials show that a drug that restores the body's natural production of testosterone has no negative effect on a man's sperm count while a topical testosterone gel causes a significant drop. The findings could change the way men are treated for low testosterone. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 27, 2015 Category: Science Source Type: news

Restoring testosterone rather than replacing it helps safeguard a man's fertility
(Wiley) Restoring testosterone production in men may be as effective as replacing it, without compromising their fertility. Two phase III clinical trials show that a drug that restores the body's natural production of testosterone has no negative effect on a man's sperm count while a topical testosterone gel causes a significant drop. The findings, which are published in BJU International, could change the way men are treated for low testosterone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 27, 2015 Category: Global & Universal Source Type: news

Attorneys for National Testosterone Lawsuits Provide Latest Court News
In national testosterone lawsuit news, the Onder Law Firm reports that the court deferred multiple claims against defendant Besins; counsel to set Discovery schedule for allegations of heart attack...(PRWeb October 05, 2015)Read the full story at http://www.prweb.com/releases/androgel-heart-attack/testosterone-lawsuit-news/prweb12998037.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 5, 2015 Category: Pharmaceuticals Source Type: news

Is treating “low T” really safe and effective?
An ongoing pharmaceutical marketing blitz promises that treating “low T” with a daily prescription testosterone boost will make men with age-related decline in this hormone feel more alert, energetic, mentally sharp, and fully functional in the bedroom. But in an article published this week in the Perspectives section of The New England Journal of Medicine, a group of FDA scientists reiterated concerns over the widespread use of testosterone supplements in light of unresolved controversies over its effectiveness and long-term safety. Is testosterone replacement therapy (TRT) delivering what these men expect it ...
Source: New Harvard Health Information - August 20, 2015 Category: Consumer Health News Authors: Daniel Pendick Tags: Men's Health low T testosterone Source Type: news

AbbVie Challenges Fairness Of Upcoming Testosterone Trials
As the lawsuits against testosterone makers continue to mount, AndroGel manufacturer AbbVie is raising questions about whether the process of picking the bellwether cases is fair enough. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 17, 2015 Category: Pharmaceuticals Authors: Arlene Weintraub Source Type: news

Testosterone Gel Not Associated with Subclinical Atherosclerosis Progression, Study Suggests (FREE)
By Kelly Young Edited by Lorenzo Di Francesco, MD, FACP, FHM Use of a testosterone gel in older men with lower testosterone levels was not associated with progression of subclinical atherosclerosis in an industry-funded study published in JAMA … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 12, 2015 Category: Primary Care Source Type: news

Testosterone Therapy Isn't All It's Cracked Up To Be, Study Finds
Millions of men, mostly over the age of 50, are now using testosterone therapy to treat a broad array of symptoms -- erectile dysfunction, weight gain, listlessness -- thought to be caused by low testosterone levels, which the pharmaceutical industry in copious advertising calls "Low-T."  But a major new study from a team of researchers at Brigham and Women's Hospital in Boston -- one of the biggest double-blinded studies of the therapy so far -- indicates that testosterone doesn't work as advertised. The team, led by endocrinologist Dr. Shalender Bhasin, gave 306 men over the age of 60, all of who...
Source: Science - The Huffington Post - August 11, 2015 Category: Science Source Type: news

Testosterone Therapy Isn't All It's Cracked Up To Be, Study Finds
Millions of men, mostly over the age of 50, are now using testosterone therapy to treat a broad array of symptoms -- erectile dysfunction, weight gain, listlessness -- thought to be caused by low testosterone levels, which the pharmaceutical industry in copious advertising calls "Low-T."  But a major new study from a team of researchers at Brigham and Women's Hospital in Boston -- one of the biggest double-blinded studies of the therapy so far -- indicates that testosterone doesn't work as advertised. The team, led by endocrinologist Dr. Shalender Bhasin, gave 306 men over the age of 60, all of who...
Source: Healthy Living - The Huffington Post - August 11, 2015 Category: Consumer Health News Source Type: news

Testosterone Lawsuit News: Androgel Lawsuit Conference Held
Lawyers handling national testosterone lawsuits for the Onder Law Firm provide a testosterone lawsuit news update, reporting on a recent case management conference in the multidistrict litigation...(PRWeb July 31, 2015)Read the full story at http://www.prweb.com/releases/androgel-lawsuit/heart-attack-attorney/prweb12876140.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 31, 2015 Category: Pharmaceuticals Source Type: news

Testosterone Attorneys: Androgel Testosterone Lawsuit Center Goes...
National testosterone attorneys from the Onder Law Firm announce the release of a new mobile version of their Androgel Testosterone Lawsuit Center website; the site provides timely testosterone...(PRWeb July 30, 2015)Read the full story at http://www.prweb.com/releases/androgel-attorneys/testosterone-lawsuit/prweb12873439.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 31, 2015 Category: Pharmaceuticals Source Type: news

Testosterone Gel Not Effective for Ejaculatory DysfunctionTestosterone Gel Not Effective for Ejaculatory Dysfunction
Overall in a placebo-controlled trial, testosterone 2% gel didn't seem to improve ejaculatory delay, force, or volume, but there was possible benefit for patients whose testosterone levels were normalized. Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 28, 2015 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

AndroGel 1.62 (Testosterone Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 5, 2015 Category: Drugs & Pharmacology Source Type: news

Testosterone Lawsuit News: Federal Court Amends Order Governing...
Bernstein Liebhard LLP is representing plaintiffs in testosterone lawsuits involving AndroGel and similar Low T therapies, and the outcomes of bellwether trials may provide insight into how juries...(PRWeb June 01, 2015)Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/androgel-lawsuit/prweb12759906.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 2, 2015 Category: Pharmaceuticals Source Type: news

Carey Danis & Lowe Comments on Recently Filed Testosterone Gel...
The St. Louis law firm comments that patients and health care providers need to know all known health risks associated with a drug, such as testosterone gel, since this knowledge is key in...(PRWeb May 26, 2015)Read the full story at http://www.prweb.com/releases/carey-danis-lowe/testosterone-gel-lawsuit/prweb12743429.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 27, 2015 Category: Pharmaceuticals Source Type: news

Court Presiding Over Federal Testosterone Lawsuits Considering Defense...
Bernstein Liebhard LLP is currently representing plaintiffs who have testosterone treatment lawsuits pending in the federal multidistrict litigation, which involves allegations that AndroGel and other...(PRWeb May 19, 2015)Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/androgel-lawsuit/prweb12735119.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 20, 2015 Category: Pharmaceuticals Source Type: news

Deposition Protocol Set in National Testosterone Lawsuits
Lawyers representing plaintiffs in testosterone lawsuits for heart attack and stroke allegations at the Onder Law Firm offer testosterone lawsuit news updates and no-cost case reviews at...(PRWeb April 28, 2015)Read the full story at http://www.prweb.com/releases/testosterone-attorneys/androgel-lawsuit/prweb12683336.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 28, 2015 Category: Pharmaceuticals Source Type: news

Court Overseeing Federal Testosterone Lawsuits Issues New Amended...
Bernstein Liebhard LLP is currently representing a number of testosterone lawsuit plaintiffs who have cases pending in the federal multidistrict litigation.(PRWeb April 15, 2015)Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/androgel-lawsuit/prweb12656553.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 15, 2015 Category: Pharmaceuticals Source Type: news

Testosterone Drugs May Be Overused, FDA Warns
WASHINGTON (AP) — The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related issues like low libido and fatigue. The agency says drugmakers must clearly state in their labeling and promotions that the drugs, currently taken by millions of U.S. men, are only approved to treat low testosterone levels caused by disease or injury, not normal aging. Additionally, the FDA cautioned that the drugs may increase the risk of heart attack, stroke and other cardiovascular pro...
Source: Science - The Huffington Post - March 3, 2015 Category: Science Source Type: news

Testosterone Lawsuit News: Plaintiffs File New AndroGel Motion in...
The Firm is representing numerous testosterone lawsuit plaintiffs who allegedly suffered serious cardiovascular complications due to their use of AndroGel and other low testosterone therapy...(PRWeb February 13, 2015)Read the full story at http://www.prweb.com/releases/testosterone-lawsuit/androgel-lawsuit/prweb12517801.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 14, 2015 Category: Pharmaceuticals Source Type: news